iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Strong Trading Volume – Here’s What Happened

Posted by Carolyn Dwyer on Oct 23rd, 2024

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) shares saw an uptick in trading volume on Monday . 28,187 shares were traded during mid-day trading, a decline of 54% from the previous session’s volume of 61,305 shares.The stock last traded at $71.42 and had previously closed at $71.86.

iShares U.S. Pharmaceuticals ETF Stock Performance

The stock has a market capitalization of $716.70 million, a P/E ratio of 6.49 and a beta of 0.58. The business has a 50 day simple moving average of $71.18 and a 200-day simple moving average of $68.01.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently bought and sold shares of IHE. McElhenny Sheffield Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter valued at $18,942,000. Aptus Capital Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at $12,165,000. Rockport Wealth LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at $12,091,000. Concord Investment Counsel Inc. acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 1st quarter valued at $3,880,000. Finally, Southern Capital Advisors LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 2.4% during the 2nd quarter. Southern Capital Advisors LLC now owns 39,832 shares of the company’s stock worth $2,642,000 after buying an additional 948 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

(Get Free Report)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.